ARDIZZOIA ANTONIO

Soatti, C., Delishaj, D., D'Amico, R., Frigerio, C., Fumagalli, I., Bonsignore, F., et al. (2021). High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 12(6), 533-539 [10.5114/JCB.2020.101685]. Dettaglio

Sala, L., Cirillo, G., Riva, G., Romano, G., Giussani, C., Cialdella, A., et al. (2019). Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype. FRONTIERS IN MOLECULAR NEUROSCIENCE, 12 [10.3389/fnmol.2019.00002]. Dettaglio

Ballabio, S., Craparotta, I., Paracchini, L., Mannarino, L., Corso, S., Pezzotta, M., et al. (2019). Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3. INTERNATIONAL JOURNAL OF CANCER, 145(10), 2670-2681 [10.1002/ijc.32288]. Dettaglio

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M., et al. (2018). Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial. THE LANCET ONCOLOGY, 19(4), 474-485 [10.1016/S1470-2045(18)30116-5]. Dettaglio

Ardizzoia, A., Arnoffi, J., Colombo, I., Villa, F., Dapretto, E., Frontini, L., et al. (2008). Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC)
[Trattamento con Gefitinib nei pazienti anziani o con scarso performance status (PS), affetti da carcinoma polmonare non a piccole cellule (NSCLC)]. TRENDS IN MEDICINE, 8(2), 97-102. Dettaglio